Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 19;21(1):261.
doi: 10.1186/s12886-021-02024-z.

In vivo confocal microscopy assessment of meibomian glands microstructure in patients with Graves' orbitopathy

Affiliations

In vivo confocal microscopy assessment of meibomian glands microstructure in patients with Graves' orbitopathy

Shengnan Cheng et al. BMC Ophthalmol. .

Abstract

Background: To evaluate microstructural changes in the meibomian glands (MGs) in patients with active and inactive Graves' orbitopathy (GO), using in vivo confocal microscopy (IVCM), and to investigate the correlations between clinical and confocal findings.

Methods: Forty patients (80 eyes) with GO (34 eyes with active GO, 46 eyes with inactive GO), and 31 age- and sex-matched control participants (62 eyes) were enrolled consecutively. A researcher recorded the clinical activity score (CAS) for each patient. A complete ophthalmic examination was then performed, including external eye, ocular surface and MGs. IVCM of the MGs was performed to determine the MG acinar density (MAD), MG longest and shortest diameters (MALD and MASD), MG orifice area (MOA), MG acinar irregularity (MAI), meibum secretion reflectivity (MSR), acinar wall inhomogeneity (AWI), acinar periglandular interstices inhomogeneity (API), and severity of MG fibrosis (MF).

Results: All confocal microscopy assessments of MGs significantly differed among groups (all P = 0.000). Compared to controls, GO groups showed lower MOA (1985.82 ± 1325.30 μm2 in active GO and 2021.59 ± 1367.45 μm2 in inactive GO vs. 3896.63 ± 891.90 μm2 in controls, all P = 0.000) and MAD (87.21 ± 32.69 /mm2 in active GO and 80.72 ± 35.54 /mm2 in inactive GO vs. 114.69 ± 34.90 /mm2 in controls, P = 0.001 and 0.000, respectively); greater MALD (118.11 ± 30.23 μm in active GO and 120.58 ± 27.64 μm in inactive GO vs. 58.68 ± 20.28 μm in controls, all P = 0.000) and MASD (44.77 ± 19.16 μm in active GO and 46.02 ± 20.70 μm in inactive GO vs. 27.80 ± 9.90 μm in controls, all P = 0.000); and higher degrees of MAI, MSR, and MF (all P<0.05). Eyes with active GO had higher degrees of MAI (P = 0.015), AWI (P = 0.000), and API (P = 0.000), while eyes with inactive GO had higher degrees of MSR (P = 0.000) and MF (P = 0.017). In GO groups, AWI and API were positively correlated with CAS (r = 0.640, P = 0.000; r = 0.683, P = 0.000, respectively), and MF was negatively correlated with CAS (r = - 0.228, P = 0.042).

Conclusions: IVCM effectively revealed microstructural changes of MGs in eyes with GO and provided strong in vivo evidence for the roles of obstruction and inflammation in the ocular surface disease process. Furthermore, it revealed discernible patterns of MG abnormalities in eyes with active GO and inactive GO, which are not easily distinguishable by typical clinical examinations.

Keywords: Graves’ orbitopathy; In vivo confocal microscopy; Meibomian glands; Microstructure.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Infrared meibography images of meibomian gland (MG) dropout. Compared with controls (A), MG dropout was higher in active (B) and inactive Graves’ orbitopathy (C), which was most pronounced in active Graves’ orbitopathy (B)
Fig. 2
Fig. 2
In vivo confocal microscopy images of meibomian gland (MG) acinar density (MAD), MG acinar longest diameter (MALD), and MG acinar shortest diameter (MASD). The multipoint tool was used to evaluate the number of clearly visible acinar unit (asterisk). The straight-line selection tool was used to trace and measure the MALD (L) and MASD (S). Compared with controls (A), the acini were obviously dilated and fused in active (B) and inactive Graves’ orbitopathy (C)
Fig. 3
Fig. 3
In vivo confocal microscopy images of meibomian gland orifice. The polygon tool was used to trace and measure meibomian gland orifice area (MOA). The orifice (highligted by a circle) was round, and the interior was uniform, presented low reflection in controls (A). However, the orifice was irregular in shape, with obvious blockage of high-reflective materials (arrow) in active Graves’ orbitopathy (B), and partial fibrosis (arrow) around the orifice in inactive Graves’ orbitopathy (C)
Fig. 4
Fig. 4
In vivo confocal microscopy images of meibomian gland acinar irregularity (MAI), meibum secretion reflectivity (MSR), acinar wall inhomogeneity (AWI), and acinar periglandular interstices inhomogeneity (API). The acini were oval, and arranged neatly, with connective tissues of interstice of the acini distributing homogeneously in controls (A). However, the acini were obviously irregular in shape and arranged disorderly in active (B) and inactive Graves’ orbitopathy (C). Particularly, the reflectivity of the acinar wall, as well as the intra- and extra-space of the acini were inhomogeneous in Graves’ orbitopathy (arrows)
Fig. 5
Fig. 5
In vivo confocal microscopy images of meibomian gland fibrosis (MF). Compared with controls (A), excessive fibrosis (arrows) could be noted in active (B) and inactive Graves’ orbitopathy (C), which was most pronounced in inactive Graves’ orbitopathy (C)

References

    1. Sabini E, Leo M, Mazzi B, Rocchi R, Latrofa F, Nardi M, Vitti P, Marcocci C, Marinò M. Does Graves’ Orbitopathy ever disappear? Answers to an old question. Eur Thyroid J. 2017;6(5):263–270. doi: 10.1159/000477803. - DOI - PMC - PubMed
    1. Rotondo Dottore G, Torregrossa L, Caturegli P, Ionni I, Sframeli A, Sabini E, Menconi F, Piaggi P, Sellari-Franceschini S, Nardi M, Latrofa F, Vitti P, Marcocci C, Basolo F, Marinò M. Association of T and B Cells Infiltrating Orbital Tissues with Clinical Features of graves Orbitopathy. JAMA Ophthalmol. 2018;136(6):613–619. doi: 10.1001/jamaophthalmol.2018.0806. - DOI - PMC - PubMed
    1. Fang S, Huang Y, Liu X, Zhong S, Wang N, Zhao B, Li Y, Sun J, Wang Y, Zhang S, Gu P, Zhou H, Li B, Fan X. Interaction between CCR6+ Th17 cells and CD34+ Fibrocytes promotes inflammation: implications in Graves' Orbitopathy in Chinese population. Invest Opthalmol Vis Sci. 2018;59(6):2604–2614. doi: 10.1167/iovs.18-24008. - DOI - PubMed
    1. Novaes P, Grisolia ABD, Smith TJ. Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface. Clin Diabetes Endocrinol. 2016;2(1):19. doi: 10.1186/s40842-016-0037-5. - DOI - PMC - PubMed
    1. Edoardo V, Francesco V, Roberto S, et al. Corneal involvement in Graves' Orbitopathy: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2010;51(9):4574–4578. doi: 10.1167/iovs.10-5380. - DOI - PubMed

LinkOut - more resources